Brief: Magle Biopolymers Receives 2026 Order
Oct 22 (Reuters) - Magle Chemoswed Holding AB MAGLE.ST: MAGLE BIOPOLYMERS RECEIVES 2026 ORDER SHOWING A MATERIAL INCREASE IN DEMAND FOR ONE OF ITS PROPRIETARY DEXTRAN DERIVATIVES Source text: ID:nMFN49DScG Further company coverage: MAGLE.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Magle Chemoswed Holding AB
See all newsBrief: Magle Group Updates On Financing Restructuring, Proposed Share Issuance
Brief: Magle Chemoswed Q1 EBIT SEK -17.8 Million
Sweden's Magle Chemoswed posts Q4 loss on restructuring measures
Brief: Magle Chemoswed Q4 EBIT SEK -120.3 Million
Brief: Magle Group Begins Written Procedure For Amendments, Waivers To Bond Terms